Search Results - "Mitter, Sophie"

Regulation of Epigenetic Modifications in the Placenta during Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells by Meister, Sarah, Hahn, Laura, Beyer, Susanne, Paul, Corinna, Mitter, Sophie, Kuhn, Christina, von Schönfeldt, Viktoria, Corradini, Stefanie, Sudan, Kritika, Schulz, Christian, Kolben, Theresa Maria, Mahner, Sven, Jeschke, Udo, Kolben, Thomas

“…The aim of this study was to analyze the expression of peroxisome proliferator-activated receptor γ (PPARγ) and retinoid X receptor α (RxRα), a binding…”
Get full text

CCL22 as an independent prognostic factor in endometrial cancer patients by Mannewitz, Mareike, Kolben, Thomas, Perleberg, Carolin, Meister, Sarah, Hahn, Laura, Mitter, Sophie, Schmoeckel, Elisa, Mahner, Sven, Corradini, Stefanie, Trillsch, Fabian, Kessler, Mirjana, Jeschke, Udo, Beyer, Susanne

“…•The impact of the chemokine CCL22 on the outcome of endometrial cancer (EC) patients depends on its localization and producing cell type.•Positive…”
Get full text

Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer by Kolben, Thomas, Müller, Lena, Meister, Sarah, Keilmann, Lucia, Buschmann, Christina, Trillsch, Fabian, Burges, Alexander, Czogalla, Bastian, Mitter, Sophie, Schmoeckel, Elisa, Corradini, Stefanie, Mahner, Sven, Jeschke, Udo, Kessler, Mirjana, Beyer, Susanne

“…Purpose Endometrial cancer (EC) is the most common gynecological cancer worldwide. Treatment has been improved in recent years, but, in advanced stages,…”
Get full text

POSTER 19Regulation of epigenetic modifications in the placenta during preeclampsia: PPARγ influences H3K4me3 and H3K9ac in extravillous trophoblast cells by Meister, Sarah, Hahn, Laura, Beyer, Susanne, Paul, Corinna, Mitter, Sophie, Kuhn, Christina, von Schönfeldt, Viktoria, Corradini, Stefanie, Sudan, Kritika, Schulz, Christian, Kolben, Theresa Maria, Mahner, Sven, Jeschke, Udo, Kolben, Thomas

“…Preeclampsia is a severe pregnancy disorder with high mortality and morbidity. The only known curative therapy is the delivery of the baby. Therefore, gaining…”
Get full text

High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer by Beyer, Susanne, Müller, Lena, Mitter, Sophie, Keilmann, Lucia, Meister, Sarah, Buschmann, Christina, Kraus, Fabian, Topalov, Nicole E., Czogalla, Bastian, Trillsch, Fabian, Burges, Alexander, Mahner, Sven, Schmoeckel, Elisa, Löb, Sanja, Corradini, Stefanie, Kessler, Mirjana, Jeschke, Udo, Kolben, Thomas

“…Purpose Endometrial cancer is the most common gynecological malignancy. The helicase RIG-I, a part of the innate immune system, and EFTUD2, a splicing factor…”
Get full text